Drug Shortage Report for APO-IRBESARTAN

Last updated on 2018-08-21 History
Report ID 55791
Drug Identification Number 02386968
Brand name APO-IRBESARTAN
Common or Proper name IRBESARTAN
Company Name APOTEX INC
Active Ingredient(s) IRBESARTAN
Strength(s) 75MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-05-31
Actual start date
Estimated end date Unknown
Actual end date 2018-08-17
Shortage status Avoided shortage
Updated date 2018-08-21
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-08-21 French Compare
v3 2018-08-21 English Compare
v2 2018-07-15 French Compare
v1 2018-07-15 English Compare